Dandelion

Dandelion

Summary
Binomial	Taraxacum officinale
Family	Asteraceae
Native range	Originally native to Eurasia and North Africa; now one of the most globally distributed plants in the world, present on every inhabited continent following dispersal with European colonization. Grows wild in grassland, roadsides, disturbed ground, and lawns throughout the temperate zone; cultivated commercially for medicinal and culinary supply in Germany and France.
Parts used	Leaves (diuretic; harvested before flowering for highest bitter-principle content); root (hepatic bitter; dug in autumn from second-year plants for highest inulin content); flowers (minor; folk wine and syrup).
Pharmacy
Pharmacology

Taraxacum officinale G.H. Weber ex Wiggers -- dandelion -- is a perennial composite herb of Eurasian origin, now distributed across every inhabited continent and recognized by virtually every person alive, most of whom have at some point scattered its seeds from a spherical white clock. The French long ago named it pissenlit -- wet-the-bed -- which is an accurate clinical description of its principal medicinal action in the leaf, and it is this frankness of folk nomenclature that most concisely captures the herb's place in medicine: a plant dismissed as a weed by every suburban lawn, carrying a clinical evidence base in diuresis that most commercially marketed diuretic herbs cannot match, with the additional distinction of replenishing in the leaf the very potassium that synthetic diuretics strip away.

History and traditional use

The earliest written records of dandelion in medicine come from 11th-century Arabic physicians -- Ibn Sina listed dandelion leaf in pharmacopoeial works -- and from the Welsh Physicians of Myddfai, a 13th-century medical guild whose manuscripts record it for liver and digestive complaints.^{[citation needed]} By the 17th century T. officinale was established in every European herbal, universally respected as a hepatic bitter, a diuretic, and a spring tonic food -- the tender young leaves gathered from fields before the first flowering and eaten in salad as an annual seasonal cleanse.

The name is a corruption of the French dent-de-lion (lion's tooth), referring to the deeply ragged leaf margins; in English it became "dandelion" by the 16th century. The French pissenlit captured the leaf's diuretic force with characteristic directness; contemporary French herbalists still use the term without embarrassment, as an accurate pharmacological description rather than a vulgarity.

Nicholas Culpeper in 1653 recorded dandelion for "opening obstructions of the liver, gall, and spleen," for jaundice, and as "a sovereign remedy against the evil disposition of the body, proceeding from the badness of the blood."^{[citation needed]} These indications -- liver, spleen, fluid, blood quality -- are precisely those that the Western alterative tradition has assigned to dandelion root for the four centuries since Culpeper, with remarkable consistency across German, French, British, and American herbal schools.

Chinese medicine: Pu Gong Ying (蒲公英)

In Chinese medicine the principal species is Taraxacum mongolicum (sometimes listed as T. sinicum), though T. officinale is accepted as an equivalent in most contemporary pharmacopoeias. Under the name Pu Gong Ying, it is classified as bitter and sweet in flavor, cold in nature, entering the liver and stomach meridians. Its principal TCM indications are clearing heat and relieving toxicity -- the diagnostic category covering acute inflammatory and infectious conditions: breast abscess and mastitis (one of the most historically consistent indications in TCM practice for this herb), acute sore throat and tonsillitis, infected eyes, jaundice from damp-heat in the liver, and intestinal infection with heat signs.^{[citation needed]} The TCM mastitis indication -- Pu Gong Ying as a primary herb for acute lactation mastitis, applied both internally as a decoction and topically as a poultice of fresh crushed leaf -- is among the most specific and consistent indications in the Chinese Materia Medica and has ethnopharmacological parallels in European practice (fresh dandelion leaf poultice for skin inflammation and swelling).

Native American and post-colonial American use

As T. officinale spread with European colonization, indigenous peoples throughout North America adopted it rapidly as it naturalized across the continent. Multiple nations used it for kidney, liver, and digestive complaints -- applications consistent with the introduced European knowledge system -- suggesting either independent discovery of the same pharmacological effects or rapid adoption of European herbal knowledge through trade contact.^{[citation needed]}

Food tradition

Dandelion occupies an unusual dual role as food and medicine. Spring dandelion greens -- young leaves gathered before flowering, when bitter principles are concentrated and the leaves are most nutritionally dense -- are among the most nutritionally complete wild greens available in temperate climates, higher in vitamins A, C, and K, and in calcium, iron, and potassium, than most cultivated vegetables.^{[citation needed]} Dandelion coffee -- roasted dried root decoction -- became a wartime staple in Britain and Europe during both World Wars when coffee was rationed, and remains a gentle, caffeine-free bitter digestive tonic in current herbal practice. In France, pissenlit au lard (dandelion greens with lardons and hot vinegar dressing) is a Burgundian spring classic with a history traceable to medieval monastic cooking.

Botany and identification

Taraxacum officinale G.H. Weber ex Wiggers is placed in tribe Cichorieae (formerly Lactuceae), subfamily Cichorioideae, family Asteraceae. The species epithet officinale (of the dispensary) signals long apothecary use; the genus name derives from the Arabic tarakhshagun or the medieval Latin corruption of it, meaning bitter herb. Taraxacum is an enormously complex genus: depending on the taxonomic authority, it contains anywhere from 60 to 2,000 or more microspecies, many of which are apomictic (reproducing without fertilization, generating clonal lineages). Most commercial medicinal supply and most clinical research uses T. officinale in the broad, aggregate sense rather than any single microspecies; pharmacopoeial monographs accept this broad usage.

The plant is a perennial forming a basal rosette of deeply pinnately lobed leaves -- the lobes giving the lion's-tooth shape -- growing from a deep taproot that can reach 30 to 50 cm in established plants. The leaves are glabrous to slightly hairy; in cultivated populations they may be less deeply lobed. Hollow, leafless scapes (flower stalks) arise singly from the crown, each bearing a single bright golden composite head of ray florets only (no disk florets); this morphology distinguishes it from most other yellow composites. The well-known globular gray-white seed head (the "clock") consists of the achenes with their attached pappus (feathery parachute structures) that allow wind dispersal over considerable distances. A single plant may produce 2,000 to 12,000 seeds per year, a reproductive strategy that explains both its global success and suburban gardeners' despair.

The medicinal parts are harvested by part and season: leaves before first flowering in spring (highest bitter-principle and potassium content; preferred for diuretic use), root in autumn from second-year plants (highest inulin content; preferred for hepatic use). The spring-leaf and autumn-root distinction is not merely traditional but is pharmacologically grounded in the plant's seasonal allocation of primary metabolites.

Closely related: Taraxacum mongolicum (Pu Gong Ying; principal TCM medicinal species; used pharmacopoeially as equivalent to T. officinale).

Active constituents

Leaf constituents

The leaf is the more nutritionally dense and diuretically active part. Principal constituents include sesquiterpene lactones (taraxacin and related compounds, responsible for the bitter taste), triterpenes, polysaccharides, coumarins, carotenoids (beta-carotene and lutein; source of the leaf's nutritional vitamin-A equivalents), vitamins C and K, and, notably, minerals at concentrations that distinguish it from most vegetables: potassium content is among the highest of any leafy green, with documented values of 370 to 500 mg per 100 g fresh weight.^{[citation needed]} This mineral composition is the pharmacological basis of dandelion leaf's unique advantage among diuretics: it replenishes the urinary potassium losses it induces, preventing the hypokalemia associated with synthetic loop and thiazide diuretics.

Root constituents

The root holds a different pharmacological profile. Inulin -- a fructooligosaccharide prebiotic polysaccharide -- constitutes up to 40 percent of dry root weight in autumn-harvested material, falling to 1 to 2 percent in spring (when it has been consumed in new-growth production).^{[citation needed]} This seasonal variation is the pharmacological rationale for the traditional autumn-harvest preference. Taraxacoside, the principal bitter sesquiterpene glycoside of the root, contributes to the bitter-tonic and mild laxative actions. Phenolic acids (chicoric acid, caffeic acid derivatives), triterpenes (taraxasterol, taraxerol), and polyacetylenes complete the profile. Mineral content in the root, while lower per gram than the leaf, is still significant.

Preparations

Leaf infusion (tea): 4 to 8 g fresh or dried leaves per cup of hot water, steeped covered (volatile constituents are modest; the cover prevents steam loss rather than oil loss). Taken 2 to 3 times daily for diuretic and tonic use; or fresh leaves as salad greens (the traditional spring tonic form, maximally nutritious and minimally processed).

Root decoction: 5 to 10 g dried root in 500 ml water, simmered covered for 15 to 20 minutes; strained and drunk in 2 to 3 portions through the day. The preferred preparation for hepatic-bitter and cholagogue use; suited to the autumn-harvested root with its peak inulin content.

Root tincture: 1:5 in 40 to 45 percent ethanol from dried root; 2 to 5 ml three times daily.

Roasted root "coffee": dried root roasted until dark brown (approximately 200 degrees Celsius, 30 minutes); ground and prepared by decoction or percolation as a coffee substitute. The roasting converts much of the inulin to simpler fructose units and develops the characteristic dark, slightly bitter flavor; the hepatic bitter action is retained at reduced intensity. A gentle daily liver tonic and caffeine-free coffee alternative with a continuous history from World War II rationing.

Root powder: 2 to 4 g per day in capsule or tablet form; convenient standardized option.

Pharmacokinetics

The pharmacokinetics of T. officinale constituents have not been well characterized. Taraxacoside and related sesquiterpene lactones are likely absorbed from the gastrointestinal tract and undergo hepatic metabolism; the kinetics are not documented to the same standard as pharmaceutical preparations. Inulin from the root is not absorbed -- it passes undigested to the large intestine where it is fermented by colonic microbiota; this is entirely the intended pharmacological mechanism for its prebiotic action rather than a bioavailability problem. Polyphenolic compounds (chicoric acid, caffeic acid derivatives) are absorbed in part from the small intestine and undergo conjugation and methylation by gut enzymes and hepatic CYP enzymes.^{[citation needed]}

Pharmacodynamics

Diuretic mechanism (leaf)

The leaf's diuretic action is classified as aquaretic -- meaning it increases urine volume and sodium excretion without proportional potassium loss -- distinguishing it from synthetic diuretics (loop diuretics, thiazides) that cause significant potassium depletion. The mechanism is thought to involve inhibition of tubular sodium reabsorption by sesquiterpene lactone constituents, but the precise renal tubular pharmacology has not been fully characterized at the receptor level.^{[citation needed]} The high potassium content of the leaf preparation further buffers any net potassium loss, contributing to the clinically observed potassium-sparing profile.

Hepatic and cholagogue mechanism (root)

The bitter sesquiterpene compounds (taraxacoside and related lactones) stimulate bile secretion from the liver and gallbladder contraction -- the cholagogue action that underlies the hepatic-bitter tonic use. This mechanism is consistent with the pharmacology of other bitter Asteraceae (chicory, artichoke) and with the TCM clearing-heat-from-liver-channel framing of the same traditional indication. In animal models, dandelion root extracts have demonstrated hepatoprotective effects against carbon tetrachloride-induced hepatotoxicity and against acetaminophen toxicity, consistent with antioxidant and anti-inflammatory mechanisms.^{[citation needed]}

Anti-inflammatory mechanism

Polyphenolic compounds in the leaf and root (including chicoric acid, caffeic acid derivatives, and flavonoids) inhibit pro-inflammatory signaling cascades in cell-culture models, including reduction of LPS-stimulated NF-kB activation and suppression of pro-inflammatory cytokine release. Whether these in vitro effects translate to clinically meaningful anti-inflammatory activity in human tissue remains to be established in powered clinical trials.

Prebiotic mechanism (root inulin)

Inulin is a well-characterized prebiotic: it selectively promotes the growth of beneficial gut microbiota (principally Bifidobacterium and Lactobacillus species) by serving as a fermentable substrate for these organisms while being resistant to digestion by human gut enzymes. The effect is dose-dependent and well-established for inulin regardless of botanical source; dandelion root is one of the most concentrated natural sources of inulin outside chicory root (Cichorium intybus) and Jerusalem artichoke (Helianthus tuberosus).^{[citation needed]}

Experience

👥 No personal reports yet

⚕ No clinical reports yet

Log in to add your own experience.

Problems

Diuretic activity: human clinical evidence

Clare, Conroy, and Spelman (2009) conducted a single-day human clinical study in 17 healthy volunteers, administering an extract of Taraxacum officinale leaf (8 ml per dose from a 1:5 infusion) three times over seven hours. Urine volume and urinary frequency increased significantly between the first and second doses and between the second and third doses relative to pre-treatment baseline, demonstrating acute diuretic activity in humans. Urinary excretion of potassium was not significantly depleted, consistent with the leaf's high potassium content counterbalancing urinary losses. This study is single-day and uncontrolled (no parallel placebo arm); it establishes acute diuretic activity but does not address long-term efficacy or comparative effectiveness against synthetic diuretics.

No large-scale randomized controlled trials of dandelion leaf for clinical edema, hypertension, or fluid retention have been published. The clinical evidence base for the diuretic indication is consistent but limited in scale and rigor relative to conventional diuretics.

Hepatic and alterative uses: traditional and preclinical evidence only

The hepatic-tonic, alterative, and liver-cleansing indications that constitute the principal traditional use of dandelion root do not have a randomized clinical trial evidence base in humans. Animal models show hepatoprotective effects against chemical hepatotoxins; the bitter-tonic mechanism is pharmacologically well-grounded; the cholagogue action is consistent with the class pharmacology of sesquiterpene bitters. The absence of clinical trial data reflects the general underfunding of hepatic herbal medicine research rather than any evidence of inefficacy, but the distinction between traditional use supported by preclinical data and use supported by clinical trials should be maintained in patient-facing communication.

Anticancer activity: in vitro studies only

Ovadje and colleagues have published a series of in vitro studies demonstrating that aqueous dandelion root extract selectively induces apoptosis in human leukemia cell lines through both intrinsic and extrinsic pathways, without significant toxicity to normal peripheral blood mononuclear cells. These are laboratory findings in cell lines; they do not constitute clinical evidence of anticancer efficacy in humans. No clinical trials of dandelion root extract for cancer treatment have been completed or published. These findings are scientifically interesting and warrant further investigation but should not be represented as clinical evidence of therapeutic effect.

+ Add a problem

Titration and dosing

Leaf (diuretic, tonic)

Infusion: 4 to 8 g dried leaf per cup, 2 to 3 times daily. Fresh leaf as salad: no formal dose ceiling; traditional seasonal use is ad libitum.

Tincture (1:5 in 40 percent ethanol): 2 to 5 ml three times daily.

Root (hepatic-bitter, cholagogue, prebiotic)

Decoction: 5 to 10 g dried root per day in divided doses. Tincture (1:5): 2 to 5 ml three times daily. Powder: 2 to 4 g per day.

The traditional distinction between spring-leaf use (diuretic, nutritive tonic) and autumn-root use (hepatic-bitter, prebiotic) reflects genuine pharmacological differences in the plant across seasons and should be preserved in practice where possible.

Recreational dose ladder

Dandelion has no recreational or psychoactive profile in any documented tradition. Neither the leaf nor the root produces altered consciousness, euphoria, sedation, or any psychoactive effect at any accessible dose. The bitter taste at higher leaf or root doses is limiting; above 10 to 15 g of dried root per day, mild nausea and diarrhea occur as the dose-limiting gastrointestinal effects. No dose ladder is warranted.

+ Add a titration strategy

Effects

No effects listed yet, be the first to suggest one.

+ Add an effect

Interactions

Lithium: diuresis raises lithium levels (monitor). High vitamin K in leaf: INR variability with warfarin. Additive hypoglycemia possible with antidiabetic medicines.

Lithium: dandelion leaf's diuretic action reduces renal lithium clearance (as does any diuretic); this can elevate lithium plasma levels into the toxic range. Patients taking lithium should not use dandelion leaf preparations without medical supervision and lithium-level monitoring.^{[citation needed]}

Potassium-sparing diuretics and ACE inhibitors: dandelion leaf's potassium-retaining character combined with potassium-sparing agents (spironolactone, eplerenone) or ACE inhibitors (which reduce urinary potassium excretion) could theoretically produce hyperkalemia in vulnerable patients. The risk is low at typical leaf-infusion doses but warrants monitoring in patients with renal impairment or on potassium-sparing regimens.

Antidiabetic medicines: dandelion has mild blood-glucose-lowering properties in animal models; additive hypoglycemic effect is possible with insulin and oral antidiabetic agents. Monitor blood glucose in diabetic patients who begin regular dandelion use.

Anticoagulants (warfarin): dandelion leaves are very high in vitamin K. Patients on warfarin anticoagulation whose vitamin K intake changes significantly (including by adding large quantities of dandelion leaf to the diet) may experience INR instability. Consistency of intake is more important than avoidance.

Patient counseling

The distinction between leaf and root preparations should be communicated clearly: the diuretic action resides principally in the leaf, and the hepatic-bitter and prebiotic actions in the root. A patient seeking fluid-retention relief should use the leaf infusion; a patient seeking liver support, digestive bitters, or prebiotic gut support should use the root decoction or roasted root.

The potassium-sparing quality of the dandelion leaf diuresis is genuinely clinically relevant and worth explaining to patients who have previously been told to avoid diuretics because of potassium concerns: dandelion leaf does not cause the potassium depletion associated with furosemide or hydrochlorothiazide. This distinction is well-grounded pharmacologically, though the clinical trial evidence is limited in scale.

The anticancer cell-line findings should not be communicated to patients as evidence of clinical efficacy. The in vitro data are preliminary and interesting; no clinical benefit in cancer treatment has been established. Patients with cancer who are interested in dandelion root for general liver support or digestive use (reasonable traditional indications) should be informed of this distinction.

Safety

Dandelion is among the safest herbs in the Western pharmacopoeia for adults, children, and in pregnancy. Serious adverse events are not documented in the clinical or case-report literature at standard dietary or medicinal doses.

Gallstones: the root's cholagogue (gallbladder-stimulating) action is the principal safety concern. In patients with known gallstones, particularly large stones or any degree of bile duct obstruction, stimulating gallbladder contraction can precipitate biliary colic. Dandelion root preparations should be used with caution in patients with known cholelithiasis and are contraindicated in patients with obstructive jaundice or bile duct obstruction.

Asteraceae allergy: dandelion is in the same plant family as ragweed (Ambrosia spp.), chamomile, and chrysanthemum. Patients with documented Asteraceae contact or inhalant allergy may have cross-reactive responses to dandelion; this is most relevant for topical use of fresh plant material. Oral ingestion of dandelion in Asteraceae-allergic individuals is generally well-tolerated but warrants initial caution.

Pregnancy and lactation: dandelion leaf and root are used as food and tonic herbs in traditional midwifery without reported harm; the plant is among the herbs most consistently classified as safe in pregnancy at dietary doses. Large-dose medicinal preparations have not been formally evaluated in pregnancy trials.

Regulatory

Germany

German Commission E: dandelion root with herb (Taraxaci radix cum herba) approved for disturbances of bile flow, stimulation of diuresis, loss of appetite, and dyspepsia.

European Union

EMA HMPC: positive assessment for traditional use of dandelion root and herb for symptomatic treatment of minor digestive disorders (dyspepsia, bloating, flatulence) and as adjuvant for increased urinary output in minor urinary complaints. Traditional use listing under the EU Traditional Herbal Medicinal Products Directive.

United States

Dandelion root and leaf: GRAS (generally recognized as safe) as food; sold as a dietary supplement under DSHEA without FDA evaluation of therapeutic claims.

United Kingdom

MHRA traditional herbal registration: dandelion root preparations registered for traditional use for relief of minor digestive and urinary complaints.

Relevant anecdote

No anecdotes yet, share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.